Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003462, "name": "Nureca", "stock_name": "Nureca", "full_name": "Nureca Ltd", "name_url": "stocks-analysis/nureca", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "259.00", "chg": -8.9, "chgp": "-3.32%", "dir": -1, "prev_price": "267.90", "mcapval": "255.00 Cr", "mcap": "Micro Cap", "scripcode": 543264, "symbol": "NURECA", "ind_name": "Healthcare Services", "ind_code": 26, "indexname": "", "isin": "INE0DSF01015", "curr_date": "Mar 13", "curr_time": "", "bse_nse_vol": "9.26 k", "exc_status": "Active", "traded_date": "Mar 13, 2026", "traded_date_str": "2026 03 13", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Nureca Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-3882174", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NurecaLtd_mojoScore_3882174.png", "date": "2026-03-10 08:36:12", "description": "Nureca Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 9 March 2026. This shift reflects a combination of deteriorating technical indicators, challenging long-term fundamentals, and valuation concerns despite recent positive quarterly financial results. The company’s current Mojo Score stands at 34.0, with a Sell grade, marking a significant change in investor sentiment." }, { "title": "Nureca Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3868863", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NurecaLtd_mojoScore_3868863.png", "date": "2026-03-04 10:10:55", "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Nureca Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3849218", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NurecaLtd_mojoScore_3849218.png", "date": "2026-02-21 10:10:44", "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Nureca Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3830389", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NurecaLtd_mojoScore_3830389.png", "date": "2026-02-10 10:11:11", "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 January 2026. While this rating change reflects the company’s evolving outlook, the analysis below is based on the stock’s current fundamentals, returns, and financial metrics as of 10 February 2026, providing investors with an up-to-date perspective on its investment potential." }, { "title": "Nureca Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3810995", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3810995.png", "date": "2026-01-30 10:11:27", "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook." }, { "title": "Nureca Ltd Falls 9.26%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-falls-926-3-key-factors-driving-the-weekly-decline-3803208", "imagepath": "", "date": "2026-01-24 11:05:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Stock surged to upper circuit at ₹322.05 (+5.0%)</p>\n <p><strong>Jan 20:</strong> Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)</p>\n <p><strong>Jan 22:</strong> Continued decline to ₹290.10 (-3.20%)</p>\n <p><strong>Jan 23:</strong> Week closes at ₹282.15 (-2.74%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.310.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.282.15</div><div class=\"stat-chang..." }, { "title": "Nureca Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-hits-lower-circuit-amid-heavy-selling-pressure-and-panic-selling-3795745", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_lower_circuit_3795745.png", "date": "2026-01-20 10:00:22", "description": "Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, plunged sharply on 20 Jan 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded its maximum daily loss in recent months, reflecting a sudden shift in investor sentiment and panic selling that overwhelmed available supply." }, { "title": "Nureca Ltd Surges to Upper Circuit Amid Robust Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3794315", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_upper_circuit_3794315.png", "date": "2026-01-19 10:00:25", "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, surged to hit its upper circuit limit on 19 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹322.05, marking a maximum daily gain of 3.27%, outperforming its sector and broader market indices amid heightened liquidity and demand." }, { "title": "Nureca Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-financials-3793847", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3793847.png", "date": "2026-01-19 08:11:09", "description": "Nureca Ltd, a player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 17 January 2026. This change reflects a combination of improved technical indicators, steady financial results, and a more balanced valuation outlook despite lingering concerns over long-term fundamentals and profitability. The stock’s recent price action and quarterly performance have prompted analysts to reassess its prospects amid a challenging industry backdrop." } ], "total": 250, "sid": "1003462", "stock_news_url": "https://www.marketsmojo.com/news/nureca-1003462" }, "announcements": [ { "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011", "datetime": "31-Jan-2026", "details": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal Aryan Goyal Payal Goyal Smita Goyal & Nectar Biopharma Pvt Ltd", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011", "datetime": "28-Jan-2026", "details": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others", "source": "BSE" }, { "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011", "datetime": "28-Jan-2026", "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22", "dt": "2022-02-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 19: Stock surged to upper circuit at ₹322.05 (+5.0%)

Jan 20: Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)

Jan 22: Continued decline to ₹290.10 (-3.20%)

Jan 23: Week closes at ₹282.15 (-2.74%)

Read full news article

Nureca Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling

2026-01-20 10:00:22

Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, plunged sharply on 20 Jan 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded its maximum daily loss in recent months, reflecting a sudden shift in investor sentiment and panic selling that overwhelmed available supply.

Read full news article

Nureca Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-01-19 10:00:25

Nureca Ltd, a micro-cap player in the healthcare services sector, surged to hit its upper circuit limit on 19 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹322.05, marking a maximum daily gain of 3.27%, outperforming its sector and broader market indices amid heightened liquidity and demand.

Read full news article

Nureca Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials

2026-01-19 08:11:09

Nureca Ltd, a player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 17 January 2026. This change reflects a combination of improved technical indicators, steady financial results, and a more balanced valuation outlook despite lingering concerns over long-term fundamentals and profitability. The stock’s recent price action and quarterly performance have prompted analysts to reassess its prospects amid a challenging industry backdrop.

Read full news article